Recent Quotes (30 days)

You have no recent quotes
chg | %

IDT Australia Limited  

(Public, ASX:IDT)   Watch this stock  
Find more results for ASX: IDT
+0.0030 (3.70%)
Delayed:   3:11PM GMT+11
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range 0.08 - 0.08
52 week 0.07 - 0.19
Open 0.08
Vol / Avg. 139,415.00/113,669.00
Mkt cap 21.00M
P/E     -
Div/yield     -
EPS -0.06
Shares 248.16M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2017
Net profit margin -251.45% -151.98%
Operating margin -242.31% -155.41%
EBITD margin - -51.47%
Return on average assets -36.56% -26.13%
Return on average equity -42.30% -31.43%
Employees 156 -
CDP Score - -


45 Wadhurst Dr
Boronia, VIC 3155
+61-3-98018888 (Phone)
+61-3-98018773 (Fax)

Website links


IDT Australia Limited is engaged in the supply of products and provision of research and development and other technical services for the pharmaceutical and allied industries. The Company's segments include CMAX, Boronia and Corporate/Unallocated. Its CMAX is a clinical trial facility in Adelaide, South Australia. It has an integrated manufacturing, development and corporate facility at Boronia, Victoria. The Company specializes in manufacture of active pharmaceutical ingredients (API) and finished dose products, including beta lactams; microbiological and analytical testing; clinical packaging, and Phase I and first time in man clinical trials research and pharmacy services. Its IDT Pharma specializes in the development, scale-up and current goods manufacturing practices (cGMP) clinical and commercial manufacture of cytotoxic API and finished drug product. The Company also offers a range of clinical trial labelling, packaging and dispensing services.

Officers and directors

Alan David Fisher Chairman of the Board
Joanna Johnson Chief Financial Officer, Company Secretary
David J. Sparling Vice President - Legal and Corporate Development, Joint Company Secretary
Jane Kelly Vice President-Clinical Services
Hugh Nigel Burrill Director
Age: 54
Graeme Roy Kaufman Director
Age: 64
Mary Elisabeth Sontrop Director
Reo Shigeno Non-Executive Director